Annual report pursuant to Section 13 and 15(d)

Income Taxes

Income Taxes
12 Months Ended
Mar. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

The provision for income taxes for the periods presented in the Consolidated Statements of Operations and Comprehensive Loss represents minimum California franchise tax, Maryland and North Carolina income tax.


Income tax expense (benefit) differed from the amounts computed by applying the statutory federal income tax rate of 21% to pretax income (loss) as a result of the following:



    Fiscal Years Ended March 31,  
    2020     2019  
Computed expected tax benefit     (21.00 )%     (21.00 )%
State income taxes, net of federal benefit     0.01 %     0.00 %
Tax effect of warrant modifications     0.84 %     0.00 %
Tax effect of research and development credits     (1.60 )%     (1.92 )%
Tax effect of stock compensation     2.39 %     0.00 %
Tax effect of other non-deductible items     0.00 %     0.74 %
 Expired net operating loss carryforwards     0.36 %     0.00 %
Change in valuation allowance (federal only)     19.02 %     22.19 %
Income tax expense     0.02 %     0.01 %


Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets are as follows:

    March 31,  
    2020     2019  
Deferred tax assets:            
Net operating loss carryovers   $ 30,607,500     $ 27,190,900  
Basis differences in property and equipment     9,100       (2,700 )
Research and development credit carryforwards     2,256,400       1,840,400  
Stock based compensation     3,919,900       3,516,600  
Operating lease Right of Use asset     95,400       -  
Accruals and reserves     66,500       207,100  
Total deferred tax assets     36,954,800       32,752,300  
Valuation allowance     (36,954,800 )     (32,752,300 )
Net deferred tax assets   $ -     $ -  


Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the deferred tax assets have been fully offset by a valuation allowance. The valuation allowance increased by $4,202,500 and $7,499,900 during the fiscal years ended March 31, 2020 and 2019, respectively.


As of March 31, 2020, we had U.S. federal net operating loss carryforwards of approximately $125,125,100, which will expire in fiscal years 2021 through 2038.  As of March 31, 2020, we had state net operating loss carryforwards of approximately $64,123,000, which will expire in fiscal years 2029 through 2040. Federal net operating losses incurred in our fiscal years 2019, 2020 and thereafter will not expire. We also have federal and state research and development tax credit carryforwards of approximately $2,068,800 and $1,189,600, respectively. The federal tax credits will expire at various dates beginning in the year 2029, unless previously utilized. The state tax credits do not expire and will carry forward indefinitely until utilized.


On March 27, 2020 the U.S. enacted the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) which provides economic relief in response to the coronavirus pandemic. The CARES Act, among other things, includes provisions to allow certain net operating losses to be carried-back up to five years, to increase interest deduction limitations, and to make technical corrections to tax depreciation methods for qualified improvement property. The CARES Act may affect the corporate income taxes imposed by state governments and may result in future responses by state legislatures, some of which could have retroactive effect. The Company evaluated the provisions of the CARES Act and determined that it did not result in a material impact on the Company’s March 31, 2020 income tax accounts.


U.S. federal and state tax laws include substantial restrictions on the utilization of net operating loss carryforwards in the event of an ownership change of a corporation. We have not performed a change in ownership analysis since our inception in 1998 and accordingly some or all of our net operating loss carryforwards may not be available to offset future taxable income, if any.


We file income tax returns in the U.S. federal, Canada and various U.S. state jurisdictions. We are subject to U.S. federal and state income tax examinations by tax authorities for tax years 1998 through 2019 due to net operating losses that are being carried forward for tax purposes, but we are not currently under examination by tax authorities in any jurisdiction.


Uncertain Tax Positions


Our unrecognized tax benefits at March 31, 2020 and 2019 relate entirely to research and development tax credits. The total amount of unrecognized tax benefits at March 31, 2020 and 2019 is $814,600 and $668,700, respectively. If recognized, none of the unrecognized tax benefits would impact our effective tax rate. The following table summarizes the activity related to our unrecognized tax benefits.


    Fiscal Years Ended March 31,  
    2020     2019  
Unrecognized benefit - beginning of period   $ 668,700     $ 451,600  
Current period tax position increases     146,000       210,100  
Prior period tax position increases (decreases)     (100 )     7,000  
Unrecognized benefit - end of period   $ 814,600     $ 668,700  


Our policy is to recognize interest and penalties related to income taxes as components of interest expense and other expense, respectively. We incurred no interest or penalties related to unrecognized tax benefits in the years ended March 31, 2020 or 2019. We do not anticipate any significant changes of our uncertain tax positions within twelve months of this reporting date.